What are the limitations of the r iss myeloma?

While the r iss myeloma is highly validated, it should not replace clinical judgment. OpiCalc provides the latest evidence-based limitations for the r iss myeloma to ensure safe bedside use and optimal diagnostic accuracy.

How does the r iss myeloma compare to other Hematology scores?

The r iss myeloma is a gold-standard diagnostic tool. OpiCalc provides side-by-side clinical guidance to help clinicians choose the most specific evidence-based tool for their patient's presentation.

Is the r iss myeloma free to use?

Yes. OpiCalc provides the r iss myeloma completely ad-free and optimized for mobile bedside use, ensuring you can calculate medical risk swiftly and without distraction.

OpiCalc

927 Clinical Tools

OpiCalc

4Ts Score (HIT)aaIPI (Age-adjusted IPI)ABC Score (Massive Transfusion)Absolute Neutrophil Count Age-adjusted D-dimer Threshold aGvHD Grading (Glucksberg/MAGIC)AL Amyloidosis Staging (Mayo)Anti-Xa Monitoring Interpreter Antiphospholipid Syndrome Classification Binet / Rai Staging (CML)Blood Volume Calculator Caprini VTE Risk CISNE Score CLL-IPI Coombs-Negative Haemolysis Checklist Corrected Reticulocyte Count CRS Grading (ASTCT 2019)DAT Interpretation Algorithm Deauville Score Interpreter DIC Score (ISTH)DIPSS (MF)DIPSS-Plus (MF)DOAC Dose Selector DOAC Renal Dose Adjustment DRI (Disease Risk Index)Durie-Salmon Staging (historical)EBMT Risk Score ELN 2022 AML Risk Classification ELTS Score (CML)England & Fraser Index EUTOS Score (CML)Expected Hb Rise per RBC Unit Factor Inhibitor Bethesda Titre Interpreter Febrile Neutropaenia Risk (MASCC)Fibrinogen Replacement FLIPI (Follicular Lymphoma IPI)FLIPI-2 French TTP Score GAPSS (Global APS Score)Haemophilia Severity Classification HbS Percentage Target Calculator HCT-CI (Comorbidity Index)HEP Score Heparin Nomogram (Weight-based)Hepatic Iron Index HERDOO2 Rule HFE Haemochromatosis Risk Estimator ICANS Grading (ASTCT 2019)IMWG Response Criteria (Myeloma)IPI (International Prognostic Index)IPSID / Lugano Classification IPSS-M (Molecular IPSS)IPSS-R (Revised IPSS for MDS)Iron Deficit Calculator (Ganzoni Formula)ISS (Myeloma)ISTH Bleeding Assessment Tool (BAT)ISTH Non-Overt DIC Score ITP Bleeding Score iwCLL Response Criteria (2018)IWG ITP Response Criteria JAK2V617F Allele Burden Interpreter Karnofsky Performance Scale Leucostasis Risk Threshold Lupus Anticoagulant (LAC) Reporting Framework MAGIC aGvHD Biomarker Score MCV-based Anaemia Algorithm Mentzer Index MIPI (MCL IPI)MIPSS70+ v2.0 (MF)Mixing Study Interpretation MRD Assessment Threshold Interpreter mSMART 3.0 (Myeloma)MTP Activation Criteria NCCN-IPI NIH Chronic GvHD Scoring NTDT Iron Burden Estimator Padua RAM PBT (Paediatric BAT)PCNSL MSKCC Score PERC Rule Perioperative Anticoagulation Bridging PESI Score (PE Mortality)PLASMIC Score Platelet Increment Calculator (CCI)PNH Clone Size Interpreter R-IPI (Revised IPI)R-ISS (Revised ISS)Reticulocyte Index (RPI)Revised Geneva Score (PE)Revised Response Criteria (NHL)Revised Zubrod / ECOG Performance Shine & Lal Index Sickle Cell Disease Risk (TCD)SLiM-CRAB Criteria SOKAL Score (CML)Sokal/EUTOS/ELTS Comparison sPESI (Simplified PESI)TACO Risk Score Thalassaemia Transfusion Threshold Thrombocytopaenia Differential Thrombophilia Screening Eligibility Algorithm Time in Therapeutic Range (TTR)TLS Risk Classification Transferrin Saturation Calculator Vienna Prediction Model von Willebrand Factor Activity Interpreter Warfarin Dose Calculator Wells Score (DVT)Wells Score (PE)WHO 2022 AML Classification Mapper WHO Bleeding Scale YEARS Algorithm

R-ISS (Revised ISS)

R-ISS (Revised ISS): The modern gold standard for Myeloma staging. Integrates ISS, FISH genetics, and LDH status.

ISS Baseline

FISH Cytogenetics

LDH Level

Revised Clinical Stage (R-ISS)

—

Select ISS group, Genetics, and LDH status to determine Revised Stage.

Guidelines & Evidence

Clinical Details

Section 1

When to Use

Baseline staging of newly diagnosed Multiple Myeloma in the modern era.

Integrating clinical biomarkers (ISS) with genomic (FISH) and metabolic (LDH) risk factors.

Providing the most accurate prediction of overall and progression-free survival.

Patient Population

Adult patients with newly diagnosed, symptomatic Multiple Myeloma.

When Not to Rely on This Score Alone

Patients without FISH data — standard ISS must be used instead.

Age-specific considerations — while R-ISS is robust, patient fitness (e.g., IMWG Frailty Index) is equally important for therapy selection.

R2-ISS — for even more granular genomic integration (including 1q gain), newer updates like R2-ISS may be preferred in clinical trials.

Section 2

Formula & Logic

Criteria

Stage	Definition
I	ISS Stage I AND Standard-risk FISH AND Normal LDH
III	ISS Stage III AND (High-risk FISH OR High LDH)
II	Neither Stage I nor Stage III

What is High-risk FISH?

del(17p)

t(4;14)

t(14;16)

Estimated 5-y OS

Stage	Overall Survival (%)
I	82%
II	62%
III	40%

Section 3

Pearls/Pitfalls

The Paradigm Shift

The R-ISS acknowledges that myeloma is not just a disease of "burden" (Beta-2) but of "biology" (FISH). A patient with low burden (ISS I) but high-risk genetics (del17p) is significantly more likely to relapse early.

Section 4

Evidence Appraisal

Primary Score

Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group.

Palumbo A et al. • Journal of Clinical Oncology. 2015;33(26):2863-9.

View Source

Section 5

Literature

Consensus

Developed by the IMWG by merging data from 3,060 patients in 11 international trials. It has become the global standard for trial stratification and risk communication.

Last Comprehensive Review: 2026

Related Hematology Tools

MIPI

aaIPI

IPSID / Lugano Classification

Deauville Score Interpreter

CLL-IPI

Binet / Rai Staging

iwCLL Response Criteria

Revised Response Criteria

PCNSL MSKCC Score

ISS

Have feedback about this calculator?Let us know.